These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8407695)
21. Viral and immunologic follow up of 4 to 9 years of AIDS treatments by quadruple combinations of virostatics including integrase inhibitors applied in short sequences differing by drug rotation. Mathe G; Morette C; Hallard M; Pontiggia P; Blanquet D; Hage F Acta Pharmacol Sin; 2002 Jan; 23(1):1-15. PubMed ID: 11860730 [TBL] [Abstract][Full Text] [Related]
22. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. Domanski MJ; Sloas MM; Follmann DA; Scalise PP; Tucker EE; Egan D; Pizzo PA J Pediatr; 1995 Jul; 127(1):137-46. PubMed ID: 7608800 [TBL] [Abstract][Full Text] [Related]
23. Study results at a glance. AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922 [TBL] [Abstract][Full Text] [Related]
24. AZT delta study: major European/Australian study finds combinations better than AZT alone. King E AIDS Treat News; 1995 Oct; (no 232):3-4. PubMed ID: 11362876 [TBL] [Abstract][Full Text] [Related]
25. Studies confirm value of early and combination treatments. Vazquez E Posit Aware; 1995; VI(6):8. PubMed ID: 11363148 [TBL] [Abstract][Full Text] [Related]
27. Current perspectives on antiretroviral therapy. Fletcher CV Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101 [TBL] [Abstract][Full Text] [Related]
28. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection. Nguyen BY; Shay LE; Wyvill KM; Pluda JM; Brawley O; Cohen RB; Whitcup SM; Venzon DJ; Broder S; Yarchoan R J Infect Dis; 1993 Oct; 168(4):810-7. PubMed ID: 8397267 [TBL] [Abstract][Full Text] [Related]
29. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS. Abrams DI; Goldman AI; Launer C; Korvick JA; Neaton JD; Crane LR; Grodesky M; Wakefield S; Muth K; Kornegay S N Engl J Med; 1994 Mar; 330(10):657-62. PubMed ID: 7906384 [TBL] [Abstract][Full Text] [Related]
30. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex. Meng TC; Fischl MA; Richman DD Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707 [TBL] [Abstract][Full Text] [Related]
31. Data and safety monitoring in the Delta trial. Armitage P Control Clin Trials; 1999 Jun; 20(3):229-41. PubMed ID: 10357496 [TBL] [Abstract][Full Text] [Related]
33. 3TC approval may revive AZT's appeal. Vazquez E Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136 [TBL] [Abstract][Full Text] [Related]
34. Antiretroviral combination treatment prolongs life in people with HIV/AIDS. Cooper EC AMFAR Rep; 1996 Jan; ():1-5. PubMed ID: 11363617 [TBL] [Abstract][Full Text] [Related]
35. Antiretroviral drug resistance. Japour AJ AIDS Clin Care; 1995 Aug; 7(8):63-5, 67. PubMed ID: 11362787 [TBL] [Abstract][Full Text] [Related]
36. Targeted therapy of human immunodeficiency virus-related disease. Mitsuya H; Yarchoan R; Kageyama S; Broder S FASEB J; 1991 Jul; 5(10):2369-81. PubMed ID: 1712326 [TBL] [Abstract][Full Text] [Related]
37. Outdated yet out-of-reach: AIDS society treatment guidelines at the International Conference. Torres G GMHC Treat Issues; 1996 Sep; 10(9):7, 10-1. PubMed ID: 11363842 [TBL] [Abstract][Full Text] [Related]
38. Other AIDS drug regimens beat AZT alone, reduce clinical progression and mortality. Stephenson J JAMA; 1995 Oct; 274(15):1183-4. PubMed ID: 7563492 [No Abstract] [Full Text] [Related]
39. What they say about nucleoside drugs. Posit Aware; 1999; 10(1):28-34. PubMed ID: 11366520 [TBL] [Abstract][Full Text] [Related]